DavidAlanDulitzMD

Gastroenterology • Metairie, LA

Gastroenterologist/Owner of East Jefferson Gastroenterology, Inc.

Join to view full profile

Dr. Dulitz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Dulitz's full profile

Already have an account?

Office
4213 Saxon street
Suite 100
Metairie, LA 70006
Phone+1 504-888-0388

Fax+1 504-888-9119
Is this information wrong?

Summary

Dr. David Dulitz is a gastroenterologist in Metairie, LA and is affiliated with East Jefferson General Hospital. He received his medical degree from Louisiana State University School of Medicine in New Orleans and has been in practice 22 years. He is experienced in general gastroenterology, interventional gastroenterology, biliary tract disease, esophageal disease, and pancreatic disease.

Education & Training

Louisiana State UniversityFellowship, Gastroenterology, 2003
Louisiana State University School of MedicineResidency, Internal Medicine, 2000
Westchester Medical CenterInternship, Surgery, 1995 - 1996
Louisiana State University School of Medicine in New OrleansClass of 1995
Tulane University School of EngineeringME, Biomedical Engineering, 1987 - 1989
University of Massachusetts, AmherstBS, Mechanical Engineering, 1983 - 1987

Certifications & Licensure

NY State Medical License 1996 - 2025
LA State Medical License 1996 - 2024

Clinical Trials

YM443 in Subjects With Functional Dyspepsia Start of enrollment: 2004 Mar 10
Completed
Phase 2
Randomized Placebo-Controlled Trial of Budesonide Multi-Matrix System (MMX®) 9 Milligrams (mg) in Participants With Ulcerative Colitis Currently on a 5-Aminosalicylic Acid (5-ASA) Start of enrollment: 2012 Jan 27
Completed
Phase 3
Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC) Start of enrollment: 2013 Aug 01
Completed
Phase 3
12-Week Study of Plecanatide for CIC (The CIC3 Study) Start of enrollment: 2013 Nov 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

Rifaximin therapy for patients with irritable bowel syndrome without constipation.
Pimentel M Lembo A Chey WD Zakko S Ringel Y Yu J Mareya SM Shaw AL Bortey E Forbes WP > ;N Engl J Med . 2011 Jan 6

Committees

Co Chairman, P and T 2018 - Present
Co Chairman, P and T 2018 - Present
Co Chairman, P and T 2018 - Present
Co Chairman, P and T 2018 - Present
Chairman, P and T 2021 - 2021
Co Chairman, P and T 2018 - 2019

Professional Memberships

Hospital Affiliations

East Jefferson General HospitalMetairie, Louisiana